Trials / Withdrawn
WithdrawnNCT05980507
An Open Label, Single-arm Clinical Study Evaluating the Safety and Efficacy of ICI201 Infusion in Relapsed/Refractory Multiple Myeloma
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- The First Affiliated Hospital of Soochow University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open label, single-arm clinical study evaluating the safety and efficacy of ICI201 infusion in relapsed/refractory multiple myeloma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ICI201 | ICI201 CAR-T cell injection |
Timeline
- Start date
- 2023-10-09
- Primary completion
- 2023-10-18
- Completion
- 2023-10-18
- First posted
- 2023-08-08
- Last updated
- 2023-12-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05980507. Inclusion in this directory is not an endorsement.